Join
Live feed
·
INSIDERFilingvia Quantisnow
Cyclacel Pharmaceuticals Inc. logo

SEC Form 4: Rombotis Spiro George bought $18,000 worth of shares (4,000 units at $4.50), increasing direct ownership by 405% to 4,988 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYCC (Cyclacel Pharmaceuticals Inc.) and more on Quantisnow.